Dianthus Therapeutics | MGTA - Spese Operative

Prezzo Delle Azioni
89.78
Cambio Giornaliero
-1.88 -2.05%
Mensile
4.59%
Annuale
409.82%
Q2 Previsione
83.41




Spese Operative Cambiamento Data
Akebia Therapeutics USD 63.08M 8.26M 2025-12
Alaunos Therapeutics USD 1.19M 148K 2025-09
Avita Medical AUD 28.02M 1.55M 2025-12
Celltrion KRW 724.99B 6B 2025-09
Cspc Pharmaceutical CNY 5.91B 512.77M 2025-12
Deva Holding AS TRY 1.35B 178.26M 2023-09
Dianthus Therapeutics USD 69.82M 29.14M 2025-12
Divis Laboratories Ltd INR 18.32B 1.08B 2025-12
IQVIA Holdings USD 1.69B 4.47B 2025-12
Kangmei Pharma CNY 1.39B 144.29M 2025-09
Knight Therapeutics CAD 126.9M 8.29M 2025-12
Laboratorios Farma EUR 313.62M 17.98M 2023-12
Malin Corporation EUR 1.1M 400K 2024-12
Medical Developments International AUD 21.61M 11.59M 2025-12
Moderna USD 1.54B 259M 2025-12
Neuren Pharmaceuticals AUD 25.23M 16.54M 2025-12
Organigram Holdings CAD 83.66M 24.44M 2025-12
Organon & Co USD 906M 362M 2025-09
Ovoca Bio EUR 1.16M 4.48M 2025-06
Pharma Mar EUR 46.87M 7.24M 2025-12
Qiagen NV USD 418.54M 23.25M 2025-12
Revvity USD 626.22M 25.62M 2025-12
Sartorius EUR 693.1M 29.4M 2025-09
Sino Biopharmaceutical CNY 12.39B 1.26B 2025-06
Tectonic Therapeutic USD 21.52M 374K 2025-12
Tilray USD 237.52M 17.34M 2025-09
Viatris USD 3.86B 335.7M 2025-12
Xeris Pharmaceuticals USD 69.03M 1.38M 2025-12
Zealand Pharma A/S 775.97M 265.08M 2025-12
Zz Pientze Pharmaceu CNY 1.55B 129.66M 2025-09